ImpaQ Ecosystem•Clarivate, Scopus & CORE Data
Clarivate WoS 2024 / 2025 Data
IMPAQ
WoS SCIE Q1Scopus Q1SCImago #3,123Hybrid

Drug Design Development and Therapy

Abbreviation (ISO):DRUG DES. DEV. THER
•
Identifier (ISSN):1177-8881(Print)
•
Publisher:Dove Medical Press Ltd.
Clarivate IF (2026)
6.1↑ +1
Journal Impact Factor
IF Trend↓
WoS Quartile
Q1
WoS SCIEJCR Quartile
Clarivate WoS JCR
WoS Categories↓
JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Drug Design Development and Therapy

WoS Q1
24682.9420183.2120193.2220204.1620214.3220224.820234.720245.120256.12026
Annual Impact Factor Metric
Current (2026):6.1
Scopus SJR & RankScopus Q1
1.309
#3,123

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025
H-Index (2025)
121

121 papers with at least that number of citations each

WoS: SCIE / JCRQ1
Self-Citation Rate2.1%
Safe Level (< 15%)Warning Level (> 20%)
Self-citation below 15% indicates strong scholarly independence.
Volume & Open AccessHybrid
377articles/year
99.71% Gold OA•77.97% Original Research

Aims & Scope

Drug Design, Development and Therapy is an international, peer-reviewed, open access journal that spans the spectrum of drug design, discovery and development through to clinical applications. The journal is characterized by the rapid reporting of high-quality original research, reviews, expert opinions, commentary and clinical studies in all therapeutic areas. Specific topics covered by the journal include: Drug target identification and validation Phenotypic screening and target deconvolution Biochemical analyses of drug targets and their pathways New methods or relevant applications in molecular/drug design and computer-aided drug discovery* Design, synthesis, and biological evaluation of novel biologically active compounds (including diagnostics or chemical probes) Structural or molecular biological studies elucidating molecular recognition processes Fragment-based drug discovery Pharmaceutical/red biotechnology Isolation, structural characterization, (bio)synthesis, bioengineering and pharmacological evaluation of natural products** Distribution, pharmacokinetics and metabolic transformations of drugs or biologically active compounds in drug development Drug delivery and formulation (design and characterization of dosage forms, release mechanisms and in vivo testing) Preclinical development studies Translational animal models Mechanisms of action and signalling pathways Toxicology Gene therapy, cell therapy and immunotherapy Personalized medicine and pharmacogenomics Clinical drug evaluation Patient safety and sustained use of medicines.

Topics Covered (Recognized by AI)
Biology95.7%Medicine94.8%Internal medicine83.6%Chemistry77.2%Genetics71.8%Biochemistry69.8%Pharmacology59.1%Pathology47.4%Endocrinology40.7%Organic chemistry37.2%Psychology31.9%Immunology31.5%Surgery30.3%Physics30.1%Psychiatry26.9%Gene25.1%Bioinformatics24.6%Cell biology20.4%

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI
JCRSCIE2026

CHEMISTRY, MEDICINAL

Q1
Rank14/72
IndexSCIE
JCRSCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank43/356
IndexSCIE
JCISCIE2026

CHEMISTRY, MEDICINAL

Q1
Rank15/72
IndexSCIE
JCISCIE2026

PHARMACOLOGY & PHARMACY

Q1
Rank59/356
IndexSCIE

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year
2026Latest
IF6.1
Articles / Year722
Total Citations306
2025
IF5.1
Articles / Year762
Total Citations3,620
2024
IF4.7
Articles / Year427
Total Citations4,871
2023
IF4.8
Articles / Year283
Total Citations5,109
2022
IF4.319
Articles / Year315
Total Citations7,367

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,123Scopus Q1SCImago Profile
Scopus Coverage:2007-2026
Scopus Broad Areas:Pharmacology, Toxicology and Pharmaceutics
Scopus Citation Rank (SJR)Q1
1.309

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1
Citations / Doc (2 years)
5.98

Average citations received per document published in the 2-year window.

2-Year Citation Window
Estimated Publication Fee (APC)
$3,350 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations6,340
3-Year Documents982
Citable Documents948

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate46.3%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Drug DiscoveryQ1
Pharmaceutical ScienceQ1
PharmacologyQ1
Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth
Self-citation: 2.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):
2区 (Zone 2)Medicine
Minor Category (Specific Field):
2区CHEMISTRY, MEDICINAL
CAS Early Warning List History:
Updated annually: 2020 – 2024
2020
Not warned
2021
Not warned
2022
Not warned
2023
Not warned
2024
Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Drug Design Development and Therapy (abbr: DRUG DES. DEV. THER, ISSN: 1177-8881) is a peer-reviewed international scholarly journal in the field of CHEMISTRY, published by Dove Medical Press Ltd. in England since 2007. The periodical holds a Journal Impact Factor (JIF) of 6.10, ranking in quartile Q1 of Web of Science (SCIE), a Scopus SJR indicator of 1.309 (Q1), an H-index of 121.

The journal enforces rigorous peer evaluation with an annual output of approximately 377 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,350 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.

Publishing & Editorial Information

Detailed publisher, peer-review turnaround, and publication cycle specifications

Open Access Model
Hybrid
Publisher
Dove Medical Press Ltd.
Publication Language
English
Frequency
Periodic
Founding Year
2007
Indexing & Databases
SCIEScopusDOAJPubMed
Editorial Address
PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752

Similar Journals in Discipline

Journals in the same research field with comparable impact metrics

Record UUID: b1f34d19-1c4d-423f-9752-9b5a47178e01
Database Updated: 2026-10-01